Evidence-informed pharmacology review updated 10 November 2026. Educational material, not a substitute for institutional protocols or individual clinical care.
Overview and components
General anesthesia produces a controlled state of unconsciousness and unresponsiveness. Its components may include hypnosis, amnesia, analgesia, autonomic stability and immobility, but no single drug reliably provides every component. In particular, neuromuscular blockers cause paralysis without analgesia or unconsciousness; opioids provide analgesia without dependable hypnosis at ordinary doses. Safe anesthesia is a continuously monitored specialist practice [1,2].
Chemical and pharmacologic classification
- Intravenous hypnotics: propofol (alkylphenol), etomidate (imidazole derivative), thiopental (barbiturate) and ketamine (arylcyclohexylamine dissociative anesthetic).
- Inhaled agents: sevoflurane and isoflurane (halogenated ethers), desflurane (halogenated ether), nitrous oxide (inorganic gas); halothane is a historical halogenated alkane, not an alkylphenol.
- Analgesic adjuncts: fentanyl, remifentanil and other opioids.
- Neuromuscular blockers: rocuronium and succinylcholine, which are not general hypnotics.
Mechanisms of action
Propofol, etomidate and many volatile agents enhance GABA-A-mediated inhibition at clinically relevant concentrations, though volatile anesthesia involves multiple molecular targets including two-pore potassium channels. Ketamine is an NMDA receptor antagonist and provides dissociative anesthesia with analgesia. Nitrous oxide has NMDA-antagonist actions but is weak as a sole general anesthetic. Dexmedetomidine, a central alpha-2 agonist, supplies sedation but is not a standard sole agent for surgical general anesthesia [1].
Pharmacokinetics
IV hypnotic onset reflects rapid brain delivery; early recovery after a brief bolus often reflects redistribution, while prolonged infusion recovery depends on context-sensitive half-time, metabolism and tissue accumulation. Inhaled-agent onset and recovery are affected by blood-gas solubility, alveolar ventilation, cardiac output and uptake. Minimum alveolar concentration (MAC) is a population potency measure related to suppression of movement in 50% of subjects, not a direct measure of awareness or analgesia [1].
Adverse effects and contraindications
Propofol can cause hypotension and apnea; ketamine may elevate heart rate/BP and cause emergence reactions; etomidate suppresses adrenal steroid synthesis transiently. Volatile agents and succinylcholine can trigger malignant hyperthermia in genetically susceptible patients. Severe reactions require immediately stopping triggers, giving dantrolene and resuscitation via an established malignant-hyperthermia protocol. Opioid and sedative combinations can cause respiratory suppression; regional and IV agents require procedure-specific risk reviews [1].
Monitoring and neuromuscular recovery
Continuous clinical observation plus oxygenation, ventilation, circulation and temperature monitoring are essential; end-tidal CO2 and oxygen monitoring are integral to most general anesthetics. Neuromuscular blockade demands quantitative monitoring and a train-of-four ratio ≥0.9 before extubation according to 2023 ASA guidance. Awareness risk, airway difficulty and postoperative nausea need individualized prevention plans [2].
Clinical context
Medication choice accounts for age, organ function, hemodynamic stability, procedure, pregnancy and prior anesthesia complications. Only trained clinicians with airway and resuscitation capabilities should administer general anesthesia; drug administration cannot be described as a fixed one-size-fits-all recipe [1,2].
References
- Brunton LL, Knollmann BC, editors. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 14th ed. McGraw Hill; 2023.
- Thilen SR, Weigel WA, Todd MM, et al. 2023 ASA practice guidelines for monitoring and antagonism of neuromuscular blockade. Anesthesiology. 2023;138:13–41. doi:10.1097/ALN.0000000000004379. Available from: https://doi.org/10.1097/ALN.0000000000004379
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.